Atara Biotherapeutics
ATRA
ATRA
144 hedge funds and large institutions have $910M invested in Atara Biotherapeutics in 2022 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 52 increasing their positions, 44 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.1% less ownership
Funds ownership: 4.31% → 4.21% (-0.1%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
39% less capital invested
Capital invested by funds: $1.5B → $910M (-$590M)
Holders
144
Holding in Top 10
2
Calls
$1.55M
Puts
$109K
Top Buyers
| 1 | +$18.1M | |
| 2 | +$16.7M | |
| 3 | +$9.97M | |
| 4 |
JP Morgan Chase
New York
|
+$7.18M |
| 5 |
Renaissance Technologies
New York
|
+$5.29M |
Top Sellers
| 1 | -$11.8M | |
| 2 | -$11.3M | |
| 3 | -$9.72M | |
| 4 |
N
Natixis
Paris,
France
|
-$5.34M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.74M |